HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thermosensitive liposomes for the delivery of gemcitabine and oxaliplatin to tumors.

Abstract
The majority of ultrafast temperature sensitive liposome (uTSL) formulations reported in the literature deliver the highly membrane permeable drug, doxorubicin (DOX). Here we report on the study of the uTSL formulation, HaT (Heat activated cytoToxic, composed of the phospholipid DPPC and the surfactant Brij78) loaded with the water-soluble, but poorly membrane permeable anticancer drugs, gemcitabine (GEM) and oxaliplatin (OXA). The HaT formulation displayed ultrafast release of these drugs in response to temperature, whereas attempts with LTSL (Lyso-lipid Temperature Sensitive Liposome, composed of DPPC, MSPC, and DSPE-PEG) were unsuccessful. HaT-GEM and HaT-OXA both released >80% of the encapsulated drug within 2 min at 40-42 °C, with <5% drug leakage at 37 °C after 30 min in serum. The pharmacokinetic profile of both drugs was improved by formulating with HaT relative to the free drug, with clearance reduced by 50-fold for GEM and 3-fold for OXA. HaT-GEM and HaT-OXA both displayed improved drug uptake in the heated tumor relative to the unheated tumor (by 9-fold and 3-fold, respectively). In particular, HaT-GEM showed 25-fold improved delivery to the heated tumor relative to free GEM and significantly enhanced antitumor efficacy with complete tumor regression after a single dose of HaT-GEM. These data suggest that uTSL technology can also be used to deliver nonmembrane permeable drugs via an intravascular ultrafast release mechanism to great effect.
AuthorsJonathan P May, Mark J Ernsting, Elijus Undzys, Shyh-Dar Li
JournalMolecular pharmaceutics (Mol Pharm) Vol. 10 Issue 12 Pg. 4499-508 (Dec 02 2013) ISSN: 1543-8392 [Electronic] United States
PMID24152292 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Liposomes
  • Organoplatinum Compounds
  • Phospholipids
  • Surface-Active Agents
  • Oxaliplatin
  • Deoxycytidine
  • Polyethylene Glycols
  • octadecyl polyoxyethylene ether
  • Gemcitabine
Topics
  • Animals
  • Antineoplastic Agents (chemistry, pharmacokinetics, pharmacology)
  • Cell Line, Tumor
  • Chemistry, Pharmaceutical (methods)
  • Deoxycytidine (analogs & derivatives, chemistry, pharmacokinetics, pharmacology)
  • Female
  • Liposomes (chemistry, pharmacokinetics, pharmacology)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Organoplatinum Compounds (chemistry, pharmacokinetics, pharmacology)
  • Oxaliplatin
  • Phospholipids (chemistry)
  • Polyethylene Glycols (chemistry)
  • Surface-Active Agents (chemistry)
  • Temperature
  • Tissue Distribution
  • Gemcitabine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: